At the recent IACFS conference, researcher Paul Nestadt described findings from a study of neurometabolites in CFS undertaken by a team of researchers led by Dr. Dikoma Shungu and funded the CFIDS Association.
In an attempt to understand the neurobiological effects of CFS and to discern potential biomarkers for the illness, these researchers used cross-sectional neuroimaging to compare regional brain metabolite levels and to examine the association of the neurochemical findings with the symptomology of the illness.
Remainder of the article is located here.
Leave a Reply